197 related articles for article (PubMed ID: 38365924)
1. High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair.
Dhakar SS; Galera-Prat A; Lehtiö L
Sci Rep; 2024 Feb; 14(1):3875. PubMed ID: 38365924
[TBL] [Abstract][Full Text] [Related]
2. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
Kurgina TA; Lavrik OI
Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
[TBL] [Abstract][Full Text] [Related]
3. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
Suskiewicz MJ; Zobel F; Ogden TEH; Fontana P; Ariza A; Yang JC; Zhu K; Bracken L; Hawthorne WJ; Ahel D; Neuhaus D; Ahel I
Nature; 2020 Mar; 579(7800):598-602. PubMed ID: 32028527
[TBL] [Abstract][Full Text] [Related]
4. HTS discovery of PARP1-HPF1 complex inhibitors in cancer.
Kellett T; Noor R; Zhou Q; Esquer H; Sala R; Stojanovic P; Rudolph J; Luger K; LaBarbera DV
SLAS Discov; 2023 Dec; 28(8):394-401. PubMed ID: 37844763
[TBL] [Abstract][Full Text] [Related]
5. HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage.
Smith R; Zentout S; Rother M; Bigot N; Chapuis C; Mihuț A; Zobel FF; Ahel I; van Attikum H; Timinszky G; Huet S
Nat Struct Mol Biol; 2023 May; 30(5):678-691. PubMed ID: 37106138
[TBL] [Abstract][Full Text] [Related]
6. Dual function of HPF1 in the modulation of PARP1 and PARP2 activities.
Kurgina TA; Moor NA; Kutuzov MM; Naumenko KN; Ukraintsev AA; Lavrik OI
Commun Biol; 2021 Nov; 4(1):1259. PubMed ID: 34732825
[TBL] [Abstract][Full Text] [Related]
7. Slow Dissociation from the PARP1-HPF1 Complex Drives Inhibitor Potency.
Stojanovic P; Luger K; Rudolph J
Biochemistry; 2023 Aug; 62(16):2382-2390. PubMed ID: 37531469
[TBL] [Abstract][Full Text] [Related]
8. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
[TBL] [Abstract][Full Text] [Related]
9. HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.
Gibbs-Seymour I; Fontana P; Rack JGM; Ahel I
Mol Cell; 2016 May; 62(3):432-442. PubMed ID: 27067600
[TBL] [Abstract][Full Text] [Related]
10. The HPF1-dependent histone PARylation catalyzed by PARP2 is specifically stimulated by an incised AP site-containing BER DNA intermediate.
Kurgina TA; Moor NA; Kutuzov MM; Lavrik OI
DNA Repair (Amst); 2022 Dec; 120():103423. PubMed ID: 36356486
[TBL] [Abstract][Full Text] [Related]
11. HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.
Sun FH; Zhao P; Zhang N; Kong LL; Wong CCL; Yun CH
Nat Commun; 2021 Feb; 12(1):1028. PubMed ID: 33589610
[TBL] [Abstract][Full Text] [Related]
12. Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs.
Rudolph J; Roberts G; Luger K
Nat Commun; 2021 Feb; 12(1):736. PubMed ID: 33531508
[TBL] [Abstract][Full Text] [Related]
13. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
[TBL] [Abstract][Full Text] [Related]
14. HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.
Rudolph J; Roberts G; Muthurajan UM; Luger K
Elife; 2021 Mar; 10():. PubMed ID: 33683197
[TBL] [Abstract][Full Text] [Related]
15. Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions.
Zentout S; Imburchia V; Chapuis C; Duma L; Schützenhofer K; Prokhorova E; Ahel I; Smith R; Huet S
Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2322689121. PubMed ID: 38865276
[TBL] [Abstract][Full Text] [Related]
16. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
Jain PG; Patel BD
Eur J Med Chem; 2019 Mar; 165():198-215. PubMed ID: 30684797
[TBL] [Abstract][Full Text] [Related]
17. Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin.
Bilokapic S; Suskiewicz MJ; Ahel I; Halic M
Nature; 2020 Sep; 585(7826):609-613. PubMed ID: 32939087
[TBL] [Abstract][Full Text] [Related]
18. PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites.
Lin X; Jiang W; Rudolph J; Lee BJ; Luger K; Zha S
Nucleic Acids Res; 2022 Apr; 50(7):3958-3973. PubMed ID: 35349716
[TBL] [Abstract][Full Text] [Related]
19. Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance.
Andronikou C; Rottenberg S
Trends Mol Med; 2021 Jul; 27(7):630-642. PubMed ID: 34030964
[TBL] [Abstract][Full Text] [Related]
20. Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling.
Longarini EJ; Dauben H; Locatelli C; Wondisford AR; Smith R; Muench C; Kolvenbach A; Lynskey ML; Pope A; Bonfiglio JJ; Jurado EP; Fajka-Boja R; Colby T; Schuller M; Ahel I; Timinszky G; O'Sullivan RJ; Huet S; Matic I
Mol Cell; 2023 May; 83(10):1743-1760.e11. PubMed ID: 37116497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
